Astera Labs (NASDAQ:ALAB) Trading Up 9% – Here’s What Happened

Astera Labs, Inc. (NASDAQ:ALAB)’s stock price was up 9% during trading on Wednesday . The company traded as high as $126.81 and last traded at $126.9420. Approximately 1,812,747 shares changed hands during mid-day trading, a decline of 66% from the average daily volume of 5,362,035 shares. The stock had previously closed at $116.48.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on ALAB shares. Royal Bank Of Canada began coverage on Astera Labs in a report on Wednesday, January 14th. They set an “outperform” rating and a $225.00 price target for the company. Jefferies Financial Group reaffirmed a “buy” rating on shares of Astera Labs in a research note on Wednesday, December 3rd. Northland Securities increased their price objective on shares of Astera Labs from $175.00 to $195.00 and gave the company an “outperform” rating in a research note on Tuesday, December 9th. Loop Capital started coverage on shares of Astera Labs in a report on Thursday, March 5th. They issued a “buy” rating and a $250.00 target price for the company. Finally, Morgan Stanley reaffirmed an “overweight” rating and issued a $210.00 price objective on shares of Astera Labs in a research report on Wednesday, December 3rd. Fifteen analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $195.89.

Astera Labs Stock Performance

The company has a market capitalization of $21.35 billion, a price-to-earnings ratio of 103.03, a PEG ratio of 2.41 and a beta of 1.74. The business’s 50 day moving average is $150.84 and its 200 day moving average is $169.21.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings data on Tuesday, February 10th. The company reported $0.58 EPS for the quarter, topping the consensus estimate of $0.51 by $0.07. The business had revenue of $270.58 million during the quarter, compared to the consensus estimate of $249.46 million. Astera Labs had a net margin of 25.70% and a return on equity of 16.12%. The business’s revenue for the quarter was up 91.8% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.37 earnings per share. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. Sell-side analysts predict that Astera Labs, Inc. will post 0.34 EPS for the current year.

Insider Buying and Selling at Astera Labs

In related news, Director Jack R. Lazar sold 7,500 shares of the firm’s stock in a transaction on Thursday, March 5th. The shares were sold at an average price of $119.80, for a total transaction of $898,500.00. Following the completion of the transaction, the director owned 87,351 shares of the company’s stock, valued at $10,464,649.80. This trade represents a 7.91% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, General Counsel Philip Mazzara sold 10,000 shares of the business’s stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $117.47, for a total transaction of $1,174,700.00. Following the transaction, the general counsel owned 128,084 shares of the company’s stock, valued at $15,046,027.48. This represents a 7.24% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders sold 224,292 shares of company stock worth $27,676,069. Corporate insiders own 12.50% of the company’s stock.

Hedge Funds Weigh In On Astera Labs

Institutional investors have recently modified their holdings of the stock. Mitsubishi UFJ Asset Management Co. Ltd. lifted its stake in shares of Astera Labs by 94.6% in the 2nd quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 109,576 shares of the company’s stock valued at $9,908,000 after purchasing an additional 53,276 shares during the period. Bank of New York Mellon Corp boosted its holdings in Astera Labs by 34.5% during the second quarter. Bank of New York Mellon Corp now owns 522,093 shares of the company’s stock worth $47,208,000 after buying an additional 133,961 shares in the last quarter. Geneva Partners LLC acquired a new stake in Astera Labs during the third quarter valued at $1,876,000. Handelsbanken Fonder AB increased its holdings in Astera Labs by 289.5% in the third quarter. Handelsbanken Fonder AB now owns 126,200 shares of the company’s stock valued at $24,710,000 after buying an additional 93,800 shares in the last quarter. Finally, Corient Private Wealth LLC acquired a new position in shares of Astera Labs in the second quarter worth about $543,000. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.